Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | Adicet Bio, Inc. ACET | TANG CAPITAL MANAGEMENT, LLC | 8,216,960 9.970% | 8,216,960 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | AnaptysBio, Inc. ANAB | TANG CAPITAL MANAGEMENT, LLC | 1,330,879 4.400% | 1,330,879 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | BioAtla, Inc. BCAB | TANG CAPITAL MANAGEMENT, LLC | 874,076 1.800% | 874,076 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | TANG CAPITAL MANAGEMENT, LLC | 600,000 4.980% | 600,000 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | TANG CAPITAL MANAGEMENT, LLC | 766,940 2.800% | 766,940 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR | TANG CAPITAL MANAGEMENT, LLC | 294,626 2.300% | 294,626 (New Position) | Filing History |
| 2024-11-14 4:00 pm Unchanged | 2024-09-30 | 13G | Quince Therapeutics, Inc. QNCX | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-08 4:56 pm Purchase | 2024-11-01 | 13D | ESSA Pharma Inc. EPIX | TANG CAPITAL MANAGEMENT, LLC | 4,300,000 9.700% | 4,300,000 (New Position) | Filing History |
| 2024-10-24 4:08 pm Purchase | 2024-10-24 | 13G | Monopar Therapeutics Inc. MNPR | TANG CAPITAL MANAGEMENT, LLC | 200,000 5.100% | 200,000 (New Position) | Filing History |
| 2024-10-08 4:20 pm Purchase | 2024-10-01 | 13D | Kezar Life Sciences, Inc. KZR | TANG CAPITAL MANAGEMENT, LLC | 720,000 9.900% | 720,000 (New Position) | Filing History |
| 2024-09-30 09:00 am Purchase | 2024-09-26 | 13G | iTeos Therapeutics, Inc. ITOS | TANG CAPITAL MANAGEMENT, LLC | 2,407,800 6.600% | 2,407,800 (New Position) | Filing History |
| 2024-09-18 4:26 pm Purchase | 2024-09-16 | 13D | Singular Genomics Systems, Inc. OMIC | TANG CAPITAL MANAGEMENT, LLC | 372,000 14.900% | 372,000 (New Position) | Filing History |
| 2024-09-12 4:10 pm Purchase | 2024-09-06 | 13D | Aurinia Pharmaceuticals Inc. AUPH | TANG CAPITAL MANAGEMENT, LLC | 7,229,500 5.100% | 7,229,500 (New Position) | Filing History |
| 2022-04-21 4:00 pm Purchase | 2022-04-11 | 13G | Inspirato Incorporated ISPO | TANG CAPITAL MANAGEMENT, LLC | 121,630 5.000% | 121,630 (New Position) | Filing History |
| 2022-04-21 4:00 pm Purchase | 2022-04-11 | 13G | ASLAN Pharmaceuticals Limited ASLN | TANG CAPITAL MANAGEMENT, LLC | 469,903 5.400% | 469,903 (New Position) | Filing History |